In the BioHarmony Drug Report Database
Amphotericin b
Abelcet, Ambisome, Amphotec, Fungizone (amphotericin b) is a small molecule pharmaceutical. Amphotericin b was first approved as Abelcet on 1982-01-01. It is used to treat aids-related opportunistic infections, aspergillosis, blastomycosis, chronic mucocutaneous candidiasis, and coccidioidomycosis amongst others in the USA.
Trade Name
|
Abelcet, Ambisome, Amphotec, Fungizone |
|---|---|
Common Name
|
amphotericin b |
ChEMBL ID
|
CHEMBL267345 |
Indication
|
aids-related opportunistic infections, aspergillosis, blastomycosis, chronic mucocutaneous candidiasis, coccidioidomycosis, cryptococcal meningitis, cutaneous candidiasis, cystitis, fungemia, histoplasmosis, mycoses, neutropenia, paracoccidioidomycosis, peritonitis, sporotrichosis, urinary tract infections, visceral leishmaniasis, zygomycosis |
Drug Class
|
Image (chem structure or protein)